category,datetime,headline,id,image,related,source,summary,url
company,1768832220,CytomX Stock Rises 31% in a Month: Here's What You Should Know,138177976,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,CTMX's share jumps 31% in a month after it outlined pipeline progress and 2026 goals led by Varseta-M in advanced colorectal cancer.,https://finnhub.io/api/news?id=c9f2832a6ce58830b0db1e61a3f0309cacc0c0d92b6c5b9e4e66351971909b84
company,1768799249,Moderna (MRNA) Valuation Check After Raised 2025 Outlook And Cost Cuts At JPMorgan Conference,138174562,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,"Moderna (MRNA) has jumped back into focus after its JPMorgan Healthcare Conference update, where management lifted the 2025 revenue forecast to about US$1.9b, cut operating expense guidance by US$200m, and pointed to a stronger cash position. See our latest analysis for Moderna. The 21.95% 7 day share price return and 53.56% 90 day share price return suggest momentum has picked up recently. However, the 22.81% 1 year total shareholder return contrasts with weak 3 and 5 year total shareholder...",https://finnhub.io/api/news?id=a7a6ef6ebea69d248bd5352dc6e2278c8f36467a2b15e606ca9f06290ae6cd2d
company,1768797310,3 Healthcare Stocks Walking a Fine Line,138179175,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,MRNA,Yahoo,"From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 23.7% gain over the past six months, beating the S&P 500 by 13.6 percentage points.",https://finnhub.io/api/news?id=646602d8b51f4849bf6e4b5d0f1342a562741eb6832d44e7fb42de96bc974def
